411 related articles for article (PubMed ID: 17587882)
61. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England.
Phekoo KJ; Richards MA; Møller H; Schey SA;
Haematologica; 2006 Oct; 91(10):1400-4. PubMed ID: 17018393
[TBL] [Abstract][Full Text] [Related]
62. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
63. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
64. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia.
Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K
Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279
[TBL] [Abstract][Full Text] [Related]
65. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
[TBL] [Abstract][Full Text] [Related]
66. Is it safe to avoid bone marrow examination in suspected itp?
Naithani R; Kumar R; Mahapatra M; Agrawal N; Pati HP; Choudhry VP
Pediatr Hematol Oncol; 2007; 24(3):205-7. PubMed ID: 17454791
[TBL] [Abstract][Full Text] [Related]
67. Grading of marrow fibrosis in chronic myeloid leukemia--a comprehensive approach.
Rao S; Sen R; Singh S; Ghalaut PS; Arora BB
Indian J Pathol Microbiol; 2005 Jul; 48(3):341-4. PubMed ID: 16761746
[TBL] [Abstract][Full Text] [Related]
68. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
Mendeleeva LP
Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
[No Abstract] [Full Text] [Related]
69. Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders.
Douglas VK; Tallman MS; Cripe LD; Peterson LC
Am J Clin Pathol; 2002 Jun; 117(6):844-50. PubMed ID: 12047134
[TBL] [Abstract][Full Text] [Related]
70. Bone marrow biopsy in clinical medicine: an overview.
Frisch B; Bartl R; Burkhardt R
Haematologia (Budap); 1982; 15(3):245-85. PubMed ID: 6764442
[TBL] [Abstract][Full Text] [Related]
71. CD117 Expression as an aid to identify immature myeloid cells and foci of ALIP in bone marrow trephines.
Naresh KN; Lampert IA
Am J Hematol; 2006 Jan; 81(1):79. PubMed ID: 16369968
[No Abstract] [Full Text] [Related]
72. Harlequin cell: Ubiquitous or pathognomic?
Jain G; Kumar C; Chopra A
Int J Lab Hematol; 2020 Apr; 42(2):e42-e44. PubMed ID: 31424608
[No Abstract] [Full Text] [Related]
73. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach.
Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
Ann Hematol; 2007 May; 86(5):311-27. PubMed ID: 17375301
[TBL] [Abstract][Full Text] [Related]
74. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
[TBL] [Abstract][Full Text] [Related]
75. Focus on myeloproliferative diseases and myelodysplastic syndromes.
Van Etten RA; Shannon KM
Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
[No Abstract] [Full Text] [Related]
76. Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases.
Vardiman JW
Semin Diagn Pathol; 2003 Aug; 20(3):154-79. PubMed ID: 14552429
[TBL] [Abstract][Full Text] [Related]
77. Myelodysplastic syndromes: more prevalent than we know.
Sandhu SK; Sekeres MA
Geriatrics; 2008 Nov; 63(11):10-7. PubMed ID: 18998762
[TBL] [Abstract][Full Text] [Related]
78. Myelodysplasia: clinical and morphological aspects and treatment.
Geary CG
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():138-40. PubMed ID: 2653491
[No Abstract] [Full Text] [Related]
79. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
Bain BJ
Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
[TBL] [Abstract][Full Text] [Related]
80. Diagnostic and prognostic value of colony formation of hematopoietic progenitor cells in myeloid malignancies.
Ohler L; Geissler K; Hinterberger W
Wien Klin Wochenschr; 2003 Aug; 115(13-14):537-46. PubMed ID: 13677271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
